Boardroom Alpha
Meeting calendar
AZTA · Annual meeting · Wednesday, January 28, 2026

Azenta Inc

10 nominees · 4 ballot items.

The proxy includes four proposals: 1) election of ten directors; 2) advisory vote on named executive officer compensation; 3) amendment to increase shares reserved under the 2020 Equity Incentive Plan by 2,750,000; and 4) ratification of PwC as independent registered public accounting firm for 2026.

Market cap
$1.2B
1Y TSR
-24.3%
Board grade
C-
Record date
Dec 3, 2025
Filing
DEF 14A
Meeting concluded · Jan 28, 2026

Follow how the vote landed and what changed on Azenta Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of the ten director nominees listed in this proxy statement.

  2. 2

    Advisory Vote on Executive Compensation

    ManagementBoard: FOR

    Advisory vote on the compensation of named executive officers as disclosed in this proxy statement.

  3. 3

    Approval of an Amendment to the Company’s 2020 Equity Incentive Plan

    ManagementBoard: FOR

    Approval of an amendment to increase the aggregate number of shares reserved for issuance under the 2020 Plan by 2,750,000.

  4. 4

    Ratification of the Selection of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2026.

Director elections

Nominees on the ballot10

Independent
Tenure on this board
1.7 yrs
Also a director at
Brightview Holdings Inc (BV)Livewire Group Inc (LVWR)
Independent
Tenure on this board
1.5 yrs
Also a director at
Entrada Therapeutics Inc (TRDA)
Independent
Tenure on this board
2.5 yrs
Also a director at
Standard Biotools Inc (LAB)Repligen Corp (RGEN)
Independent
Tenure on this board
3.5 yrs
Also a director at
Exagen Inc (XGN)Aurinia Pharmaceuticals Inc (AUPH)
Ownership

Top institutional holders10

Latest 13F quarter
1Politan Capital Management LP10.0%4,622,450$98M
2BlackRock, Inc.9.5%4,386,525$93M
3Conestoga Capital Advisors, LLC6.2%2,844,546$60M
4VANGUARD PORTFOLIO MANAGEMENT LLC5.3%2,450,492$52M
5DIMENSIONAL FUND ADVISORS LP4.4%2,014,353$43M
6VANGUARD CAPITAL MANAGEMENT LLC4.0%1,828,291$39M
7MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.9%1,785,885$38M
8STATE STREET CORP3.8%1,762,423$37M
9Allspring Global Investments Holdings, LLC3.5%1,613,426$34M
10BlackRock, Inc.3.2%1,492,897$32M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Azenta Inc 2026 annual meeting?
Azenta Inc (AZTA) holds its 2026 annual shareholder meeting on Wednesday, January 28, 2026.
What is the record date for the Azenta Inc 2026 meeting?
The record date for the Azenta Inc 2026 meeting is Wednesday, December 3, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Azenta Inc's 2026 meeting?
The board is presenting 10 director nominees at the Azenta Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Azenta Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Azenta Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer